| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.099 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |